MILWAUKIE, Ore. — The American Association of Homeopathic Pharmacists (AAHP), representing the major manufacturers and distributors of homeopathic drugs, confirms that it is unaware of any homeopathic literature or clinical trial that specifically support the use of any homeopathic drug for prevention or treatment on the emerging 2019 Novel Coronavirus and does not recommend its use in treating 2019-nCoV. This clarification comes in the wake of questions about homeopathic treatments for the new respiratory virus first identified in Wuhan, China.

Accordingly, the AAHP reminds manufacturers, retailers, healthcare providers and consumers alike to follow the advice of public health officials during all health crises. Up-to-date information on the Coronavirus can be found through the Centers for Disease Control and Prevention (CDC) at https://www.cdc.gov/coronavirus/.

CDC’s website states this is a rapidly evolving situation. While symptoms may include fever, cough, and shortness of breath, confirmed infections have ranged from people with little to no symptoms to people being severely ill and dying. AAHP therefore believes the promotion of homeopathic medicines for use in this disease is contrary to the best interests of patients and populations at risk.

CDC also states that there is currently no vaccine to prevent 2019-nCoV infection, nor an antiviral treatment. The agency urges everyday prevention actions, such as handwashing, etc. and recommends people who think they may have been exposed to 2019-nCoV to contact their healthcare provider immediately.

As in the U.S., citizens of other countries should follow the advice of their public health authorities since situations may differ during this global challenge.

AAHP encourages manufacturers and marketers of homeopathic medicines to use resources at their disposal to promote actions recommended by the public health service, including CDC, and to accurately inform the public regarding steps they should take in the face of this challenging disease.

###

 

Founded in 1923, the American Association of Homeopathic Pharmacists (AAHP) is the leading industry association for the manufacturers, distributors and marketers of homeopathic drugs. AAHP promotes excellence in the practice of homeopathic pharmacy, manufacturing, marketing and distribution by supporting the requirements, criteria and published guidelines in the HPUS, relevant Federal statutes, as well as other industry regulations/compendia — all to help members provide safe, effective homeopathic medicines to consumers, retailers and healthcare practitioners.

 

Contact: Eric Foxman by email at info@AAHP.info or by phone at 513-402-8847